Clinical Trial Update: Fingerprick Autologous Blood (FAB) in Mebomian Gland Dysfunction (MGD) [NA]

View source ↗

Summary

Clinical trial update for Fingerprick Autologous Blood (FAB) therapy in Meibomian Gland Dysfunction and Dry Eye Disease; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Meibomian Gland Dysfunction

Drugs mentioned

• Fingerprick Autologous Blood (FAB)

Snippet

Sponsor: Bedford Hospital NHS Trust | Conditions: Meibomian Gland Dysfunction, Dry Eye Disease | NA | Status: UNKNOWN